007: Quality Data For FDA Submissions With Dr. Robert Hariri
Business Of Biotech
00:00
Introduction
Matt Piller: Welcome back to the business of biotech. The next four episodes are going to take some deep dives into topics including data quality, GMP, CMC considerations and gap analysis. We've got some great guests lined up to guide us, folks like Dr. Shabir Anik, CTO at SutraO Bio,. Dr. Edith Perez and Nathan Ayl, CMO and CTO respectively at Bolt Bio Therapeutics., Dr. Pablo Valenzuela and Christian Hernandez Cuevas, CEO and COO at Andy's Biotechnologies. Today we're going to have a discussion about quality data and FDA submissions.
Play episode from 00:00
Transcript
